Institutional investors purchased a net $1.8 million shares of NLNK during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 46.09% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 235.9 Thousand shares of NewLink Genetics Corp
FIRST EAGLE INVESTMENT MANAGEMEN... Bought 148.8 Thousand shares of NewLink Genetics Corp